Skip to content
Posted on March 29, 2023 by: eqs

Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China

PR in the Philippines

Press Releases, Company Events, Business Chances in the Philippines

Posted on March 29, 2023 by: eqs

Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China

  • Home
  • SEAPRWire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • Contact

Biden and Trump spar over East Palestine train disaster in US

  • Home
  • Life
  • Biden and Trump spar over East Palestine train disaster in US
Posted on February 23, 2023

Clean up work continues in East Palestine, Ohio

Categories: Life

Post navigation

Doubleview Provides Update on Milestone 56% Scandium Phosphate Recovery in First Phase Metallurgical Testing at the HAT Deposit
Wang Yi meets Putin in sign of deepening China-Russia ties

Categories

  • ACN Newswire
  • EQS Newswire
  • JCN Newswire
  • Life
  • Manila
  • People
  • SEAPRWire

Recent Posts

  • Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China
  • NEC Technology Successfully Predicts High Risk Areas for Presence of Landmines
  • Society Pass’ (Nasdaq: SOPA) Thoughtful Media Group Launches in Vietnam Market, Revolutionizing the Creator Economy with Integrated Marketing Services
  • Paribus Announces Mainnet v1 Launch
  • Pagoda Group Profit Attributable to the Owners of the Company Surges 40.4% in FY2022

Menu

  • Home
  • About Us
  • Contact Us
  • Term of Use
  • RSS

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • PostVN
  • VOASG
  • EventPH
Copyright © 2023 PR in the Philippines